Microsoft to Collaborate with Apollo Hospitals for AI-Based Diagnosis of Cardiac Disorders

Google+ Pinterest LinkedIn Tumblr +

Microsoft announced partnership with Apollo Hospitals on March 8, 2018, to expand its healthcare artificial intelligence (AI) services targeting cardiac disorders

The partnership was announced at the Healthcare Information and Management Systems Society (HIMSS) annual conference and exhibition in Las Vegas. Microsoft Intelligent Network for Eyecare (MINE), which is a part of Microsoft Healthcare NExT is focused on developing innovative technologies in healthcare through artificial intelligence and cloud computing. Initially, the segment of the company was dedicated to vision impairments.

The collaboration of company with Apollo hospital will develop and deploy new machine learning models to diagnose risk of cardiac disorders in patients along with assisting doctors with treatment plants. “AI Network for healthcare aims to democratize AI by empowering healthcare providers with faster, intuitive and predictable solutions and reducing the disease burden. The systems of intelligence we create can change the lives of patients and the work of medical practitioners enabling accessible healthcare to all,” said Peter Lee, Corporate Vice President (AI and Research) at Microsoft.

“Cardiac disease is amongst India’s leading causes of mortality and morbidity, which is exacting a toll on the health and well-being of our citizens,” said Sangita Reddy, Joint Managing Director, Apollo Hospitals. “The collaboration with Microsoft’s path-breaking technologies like AI and machine learning will help better predict, prevent and manage heart disease in the country,” Reddy added.


About Author

Is a technology enthusiast, who has amassed a wide range of experience in the industry at a very young age. His extensive background of computer software and programming and proclivity to be up-to-date with the latest of technology upgrades and launches, helps him deliver the most intriguing and trending tech news. Contact Author

Comments are closed.